However, some studies showed that, while elevated IDO expression in surgically treated patients was correlated to shorter PFS or OS, treatment with PD-1 inhibitors showed longer PFS in patients with acral and mucosal melanoma who had elevated IDO levels. The gene discussed is IDO1; the disease is melanoma.